A recent study published by JAMA Pediatrics found that non-resistant staph infections occur more than twice as often in newborns as resistant strains. Though the bacteria respond to antibiotics, they still have nearly as high a death rate among newborns as antibiotic-resistant strains, like MRSA.
Researchers concluded that these findings point to a need for hospitals to change their infection-prevention protocols. Instead of solely screening for antibiotic resistant strains of bacteria in neonatal care facilities, they must now also screen for non-resistant strains of bacteria, as they are equally threatening to newborn babies.